(Q36932480)

17 August 2017

1 reference

title

Should surgery remain the initial treatment of "operable" breast cancer? (English)

1 reference

17 August 2017

Should surgery remain the initial treatment of “operable” breast cancer? (English)

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

22 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

22 November 2022

author name string

J. M. Kurtz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1782057

22 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1782057

22 November 2022

publication date

1 January 1991

1 reference

full work available at URL

17 August 2017

https://api.elsevier.com/content/article/PII:0277537991904086?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

https://api.elsevier.com/content/article/PII:0277537991904086?httpAccept=text/plain

22 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

European Journal of Cancer

22 November 2022

published in

1 reference

17 August 2017

volume

27

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

1539-1542

1 reference

Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial.

17 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer

22 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

22 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

22 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

22 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study

22 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

22 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer

22 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

Conservative management of operable breast cancer.Ten years experience at the Foundation Curie

22 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

Radiation therapy with or without primary limited surgery for operable breast cancer: a 20-year experience at the Marseilles Cancer Institute

22 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90408-6

22 November 2022

Identifiers

1 reference

17 August 2017

1 reference